Abstract

Introduction/Background*The Phase IIIb single-arm OPINION study was the first study to prospectively evaluate maintenance olaparib in patients with non-germline BRCA1 and/or BRCA2-mutated (non-gBRCAm) platinum-sensitive relapsed ovarian cancer (PSR OC). Median...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call